Bioasis Technologies Inc.
14 Water Street
Guilford, CT 06437
Catherine London, Executive Vice President, Corporate Communications & Investor Relations
Bioasis Technologies is a biopharmaceutical company founded in 2007 and with offices in Canada and the U.S. The company is focused on overcoming the limitations of therapeutic drug delivery across the blood-brain barrier and into the central nervous system for the treatment of neurological diseases and disorders.
Bioasis has developed a proprietary platform to deliver therapeutic drugs across the blood-brain barrier and into the central nervous system for the treatment of neurological diseases and disorders. The company is now licensing this breakthrough technology to biotechnology and pharmaceutical companies for the advancement of their neurotherapeutic programs. The in-house development programs at Bioasis are designed to develop effective treatments for patients suffering with neurological diseases. The goal of these programs is to produce symptomatic and disease-modifying treatments for brain-related diseases and disorders.
CT Employees: 4
World Employees: 8